Reply to the letter to the editor: [Comment on “The relationship between atherogenic index of plasma and no-reflow in patients with acute ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention]

Abstract

We have read with a great pleasure the letter of Dr. Cure et al. to the editor about our recent study which showed an association between atherogenic index of plasma (AIP) and no-reflow in patients with ST segment elevation myocardial infarction who underwent primary percutaneous coronary intervention. Dr Cure raises concerns about the miscalculation of AIP value that suggested choosing 'mmol/l' in equation instead of 'mg/dl'. As the AIP is the logarithmic transformation of triglyceride/ high density lipoprotein; 'mmol/l' and an alternatively 'mg/dl' units can be used in the equation to calculate AIP values. Cure et al. also argue that our patients' lipoprotein levels were lower than expected. However, in a population based study and in several studies which were held in Turkey, the mean values of lipoprotein levels in Turkish population were nearly similar with our study population findings. We thank the authors' letter for pointing out these issues which we hope to have addressed.

Comprehensive Echocardiography of Left Atrium and Left Ventricle Using Modern Techniques Helps in Better Revealing Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy

“…Russo et al in the Northern Manhattan Study of 675 patients showed that a value measured from 2D GLS for LV worse than –14.7% was a strong predictor of AF appearance [ 42 ], but this study was not concentrated on patients with HCM. Zegkos et al, in his recently published research concerning the relationship between 2D LV and LA strains and AF occurrence in the HCM population, defined the optimal cutoff values for the LV GLS (≥−14%) and LA strain (<20%) [ 43 ], which are very similar to that presented in our study.…”

The Valuable Role of Imaging Modalities in the Diagnosis of the Uncommon Presentations of COVID-19: An Educative Case Series

“…Thus, the diagnosis and management of COVID-19 have a high clinical significance. Elevation of cardiac enzymes such as cardiac troponin I and NT-proBNP are the early clues for the investigation of myocarditis [ 21 , 22 ]. While the endomyocardial biopsy is deemed the gold standard for the diagnosis of myocarditis [ 23 ], cardiac MRI is known as the gold-standard “imaging” modality for this condition [ 24 , 25 ].…”

“…While the endomyocardial biopsy is deemed the gold standard for the diagnosis of myocarditis [ 23 ], cardiac MRI is known as the gold-standard “imaging” modality for this condition [ 24 , 25 ]. Different patterns of late gadolinium enhancement in COVID-19-associated myocarditis have been acknowledged in previous studies; nonetheless, it is mainly localized in the intramural or subepicardial regions of the left ventricle and the basal-to-mid inferolateral walls [ 22 , 26 ].…”